期刊文献+

Down-regulation of p73 correlates with high histological grade in Japanese with breast carcinomas 被引量:2

Down-regulation of p73 correlates with high histological grade in Japanese with breast carcinomas
原文传递
导出
摘要 Background p73, a homologue of p53, has been located at chromosome lp36-33, a region of frequently observed loss of heterozygosity in breast cancers. The objective of the present study was to investigate the function of p73 in Japanese with breast cancers. Methods Sixty Japanese patients with breast cancer were assessed by polymerase chain reaction single strand confirmation polymorphism analysis and direct sequencing to detect the p73 allele, p73 mRNA levels were also determined in 40 out of 60 patients by reverse-transcriptional polymerase chain reaction. Results We analyzed the entire open reading frame of the p73 gene by polymerase chain reaction single strand confirmation polymorphism and sequencing, and failed to identify any mutations of p73 in the encoding regions detected. Loss of heterozygosity of p73 was infrequent and only found in 9% of breast carcinomas. We revealed a few polymorphisms with a frequency of 13%-29%, which had been reported previously. Down-regulation of p73 mRNA expression was observed in tumor tissues in comparison to the normal breast tissues. A significant inverse correlation was found between p73 transcripts and high histological grade, suggesting that down-regulated p73 expression could be related to poor prognosis in those patients. Conclusion Our results suggest that p73 may serve as a tumor suppressor gene and its expression plays a role in tumorigenesis in Japanese patients with breast cancer. Background p73, a homologue of p53, has been located at chromosome lp36-33, a region of frequently observed loss of heterozygosity in breast cancers. The objective of the present study was to investigate the function of p73 in Japanese with breast cancers. Methods Sixty Japanese patients with breast cancer were assessed by polymerase chain reaction single strand confirmation polymorphism analysis and direct sequencing to detect the p73 allele, p73 mRNA levels were also determined in 40 out of 60 patients by reverse-transcriptional polymerase chain reaction. Results We analyzed the entire open reading frame of the p73 gene by polymerase chain reaction single strand confirmation polymorphism and sequencing, and failed to identify any mutations of p73 in the encoding regions detected. Loss of heterozygosity of p73 was infrequent and only found in 9% of breast carcinomas. We revealed a few polymorphisms with a frequency of 13%-29%, which had been reported previously. Down-regulation of p73 mRNA expression was observed in tumor tissues in comparison to the normal breast tissues. A significant inverse correlation was found between p73 transcripts and high histological grade, suggesting that down-regulated p73 expression could be related to poor prognosis in those patients. Conclusion Our results suggest that p73 may serve as a tumor suppressor gene and its expression plays a role in tumorigenesis in Japanese patients with breast cancer.
出处 《Chinese Medical Journal》 SCIE CAS CSCD 2011年第15期2275-2278,共4页 中华医学杂志(英文版)
基金 This work was supported by the National Natural Science Foundation of China (No. 30973377), Major State Basic Research Development Program (No. 2011CB707705), and the Natural Science Fund of the Province of Guangdong (No. 9151800102000001).Acknowledgements: We thank Dr. Akira Nakagawara for kindly providing the sequence of the intron-exon boundaries.
关键词 P73 p53 breast cancer POLYMORPHISM loss of heterozygosity p73 p53 breast cancer polymorphism loss of heterozygosity
  • 相关文献

参考文献24

  • 1Levine AJ.p53,the cellular gatekeeper for growth and division.Cell 1997; 88:323-331.
  • 2Kaghad M,Bonnet H,Yang A,Creancier L,Biscan JC,Valent A,et al.Monoallelically expressed gene related to p53 at 1p36,a region frequently deleted in neuroblastoma and other human cancers.Cell 1997; 90:809-819.
  • 3Jost CA,Marin MC,Kaelin WG Jr.p73 is a simian[correction of human] p53-related protein that can induce apoptosis.Nature 1997; 389:191-194.
  • 4Callahan R.Genetic alterations in primary breast cancer.Breast Cancer Res Treat 1989; 13:191-203.
  • 5Nagai H,Negrini M,Carter SL,Gillum DR,Rosenberg AL,Schwartz GF,et al.Detection and cloning of a common region of loss of heterozygosity at chromosome 1p in breast cancer.Cancer Res 1995; 55:1752-1757.
  • 6Dominguez G,Silva JM,Silva J,Garcia JM,Sanchez A,Navarro A,et al.Wild type p73 overexpression and high-grade malignancy in breast cancer.Breast Cancer Res Treat 2001; 66:183-190.
  • 7Shishikura T,Ichimiya S,Ozaki T,Nimura Y,Kageyama H,Nakamura Y,et al.Mutational analysis of the p73 gene in human breast cancers.Int J Cancer 1999; 84:321-325.
  • 8Yamamoto T,Oda K,Kubota T,Miyazaki K,Takenouti Y,Nimura Y,et al.Expression of p73 gene,cell proliferation and apoptosis in breast cancer:immunohistochemical and clinicopathological study.Oncol Rep 2002; 9:729-735.
  • 9Nimura Y,Mihara M,Ichimiya S,Sakiyama S,Seki N,Ohira M,et al.p73,a gene related to p53,is not mutated in esophageal carcinomas.Int J Cancer 1998; 78:437-440.
  • 10Zhang GJ,Tsuda H,Adachi I,Fukutomi T,Yamamoto H,Hirohashi S.Prognostic indicators for breast cancer patients with one to three regional lymph node metastases,with special reference to alterations in expression levels of bcl-2,p53 and c-erbB-2 proteins.Jpn J Clin Oncol 1997; 27:371-377.

同被引文献5

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部